News

Fintel on MSN1d
Bernstein Initiates Coverage of Bilibili (BLBLF) with Outperform Recommendation
Fintel reports that on July 8, 2025, Bernstein initiated coverage of Bilibili (OTCPK:BLBLF) with a Outperform recommendation.
Fintel on MSN2d
Bernstein Initiates Coverage of Bilibili Inc. - Depositary Receipt () (BILI) with Outperform Recommendation
Fintel reports that on July 8, 2025, Bernstein initiated coverage of Bilibili Inc. - Depositary Receipt () (NasdaqGS:BILI) ...
Bernstein starts bullish on Kuaishou, Bilibili on rising video ad tide
Bernstein started coverage of Kuaishou Technology and Bilibili Inc (NASDAQ:BILI). with Outperform ratings, arguing both Chinese online‑video operators are set to capture a larger share of digital ...
Bilibili (BILI) Soars 7.66% on Launch of AI Tool
Bilibili rallied for a second day on Monday, adding 7.66 percent to close at $22.48 apiece following news that it was set to ...
Bilibili Upgrade To Buy As Margins Continue To Expand
Bilibili's valuation continues to be attractive and doesn't reflect current market consensus. Read why I'm upgrading my ...
Amazon stock falls after Prime Day spending shows 14% decline in early hours
Amazon.com Inc (NASDAQ:AMZN) stock declined as much as 2% on Tuesday following reports that Prime Day sales dropped nearly 14% in the first four hours compared to last year’s event.
KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday
The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...